Project Details
Description
ZOL446E2352: A prospective, randomized, double-blind, stratified, placebo-controlled, multi-center, 3-arm trial of the continued efficacy and safety of Zometa (every 4 weeks vs. every 12 weeks vs. placebo) in patients with documented bone metastases from
| Status | Finished |
|---|---|
| Effective start/end date | 12/1/05 → 12/31/13 |
Funding
- NOVARTIS PHARMACEUTICALS CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.